Biktarvy, formally known as bictegravir, represents a powerful single-tablet regimen for managing HIV infection. This formula combines three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the the viral ability to copy within the body, significantly lowering the viral quantity. For many in